The role of biological alcohol markers in DUI offenders appraisals for regranting of licenses;Der einsatz von biologischen alkoholmarkern in der fahreignungs- begutachtung alkoholauffälliger kraftfahrer

Blutalkohol

Volumn 41, Issue 6, 2004, Pages 12-21

  Seidl, Stephan ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Alcohol marker; Appraisal; CDT; Driving aptitude; DUI; GGT; MCV

Indexed keywords

2 PROPANOL; 5 HYDROXYTRYPTOPHOL; ACETONE; ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE DEFICIENT TRANSFERRIN; DOLICHOL; GAMMA GLUTAMYLTRANSFERASE; METHANOL; SALSOLINOL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABUSE; ALCOHOL BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONFERENCE PAPER; DRIVER LICENCE; DRIVING ABILITY; DRUNKEN DRIVING; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MACROCYTIC ANEMIA; MEAN CORPUSCULAR VOLUME; OFFENDER;

EID: 10644258887     PISSN: 00065250     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (110)

1. Bundesanstalt für Straßenwesen, Hrsg. Begutachtungs-Leitlinien zur Kraftfahrereignung des Gemeinsamen Beirats für Verkehrsmedizin beim Bundesministerium für Verkehr, Bau- und Wohnungswesen und beim Bundesministerium für Gesundheit. Bremerhaven: Wirtschaftsverlag NW; 2000. p. 40-13.
2. Chick J, Kreitman N, Plant M Mean cell volume and gamma-glutamyl- transpeptidase as markers of drinking in working men. Lancet I. 1981; 1249-1251.
3. Eckardt M J, Ryback R S, Rawlings R R, Graubard B I Biochemicaldiagnosis of alcoholism. A test of the discriminating capabilities of δ-glutamyl transpeptidase and mean corpuscular volume. J Am Med Ass. 1981;246:2707-2710.
4. Garvin R B, Foy D W, Alford G S A critical examination of gamma-glutamyl transpeptidase as a biochemical marker for alcohol abuse. Addict Behav. 1981; 6: 377-383.
5. Horner F, Kellen J A, Kingstone E, Maharaj N, Malkin A Dynamic Changes of serum gamma-glutamyl transferase in chronic alcoholism. Enzyme. 1979; 24: 217-223.
6. Kristenson H, Trell E Indicators of alcohol consumption: Comparisons between a questionnaire (Mm-MAST), interviews and serum γ-glutamyl transferase (GGT) in a health survey of middle-aged males. Brit J Addict. 1982;77:297-304.
7. Rollason J G, Pincherle G, Robinson D Serum gamma glutamyl transpeptidase in relation to alcohol consumption. Clin Chim Acta. 1972; 39: 75-80.
8. Rosman A S Utility and evaluation of biochemical markers of alcohol consumption. J Subst Abuse. 1992; 4: 277-297.
9. th International Conference on Alcohol, Drugs and Traffic Safety. Annecy: CERMT; 1997. p. 275-279.
10. Große Aldenhövel H Erhöhte Serumaktivitäten von Gamma-GT und Transaminasen im Rahmen verkehrsmedizinischer Eignungsuntersuchungen alkoholauffälliger Kraftfahrer: einige differentialdiagnostische Gesichtspunkte. Blutalkohol. 1984; 21: 471-478.
11. Haffner H T, Becker I S, Mann K Zur Sensitivität klinisch-chemischer Marker des Alkoholismus nach kurzfristiger anlassbezogener Alkoholkarenz. Blutalkohol. 1989; 26: 114-122.
12. Orrego H, Blake J E, Israel Y Relationship between γ-glutamyl transpeptidase and mean urinary alcohol levels in alcoholics while drinking and after alcohol withdrawal. Alcoholism: Clin Exp Res. 1985; 9: 10-13.
13. Wietholtz H, Colombo J P Das Verhalten der γ-Glutamyltranspeptidase und anderer Leberenzyme im Plasma während der Alkohol-Entziehungskur. Schweiz Med Wschr. 1976; 106: 981-987.
14. Gilg T Diagnose von Alkoholmißbrauch und Alkoholismus, biologische und biochemische Alkoholismus-marker bzw. -parameter. In: Soyka M, editor. Die Alkoholkrankheit - Diagnose und Therapie. Weinheim: Chapman & Hall; 1995. p. 79-104.
15. Herbay v A, Strohmeyer G Die erhöhte γ-GT (γ- Glutamyltransferase). Ursachen und Interpretationen. Dtsch Med Wochenschr. 1994; 119: 1041-1044.
16. Conigrave K M, Saunders J B, Whitfield J B Diagnostic tests for alcohol consumption. Invited review. Alcohol Alcoholism. 1995; 30: 13-26.
17. th International Conference on Alcohol, Drugs and Traffic Safety. Annecy: CERMT; 1997. p. 241-254.
18. Monteiro M G, Masur J Monitoring alcoholism treatment: the appropriateness of choice between gamma-GT or MCV evaluation after a short time of abstinence. Alcohol. 1986; 3: 223-226.
19. Hedworth-Whitty R B, Whitfield J B, Richardson R W. Serum γ-glutamyl transpeptidase activity in myocardial ischaemia. Brit Heart J. 1967; 29: 432-438.
20. Lehmann D, Prentice M, Rosalki S B Plasma γ-glutamyl transpeptidase activity following renal transplantation. Ann Clin Biochem. 1970; 7: 148-151.
21. Penn R, Worthington DJ Is serum γ-glutamyltransferase a misleading test? Br Med J. 1983; 286: 531-535.
22. Salaspuro M Marker für Alkoholismus und alkoholassoziierte Organschäden. In: Seitz H K, Lieber C S, Simanowski U A, editors. Handbuch Alkohol, Alkoholismus, alkoholbedingte Organschäden. Heidelberg: Barth; 2000. p. 96-124.
23. Rosalki S B, Tarlow D, Rau D Plasma gamma-glutamyltranspeptidase elevation in patients recieving enzyme-inducing drugs. Lancet II. 1971; 376-377.
24. Cohen J A, Kaplan M M The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Digest Dis Sci. 1979; 24: 835-838.
25. Correia J P, Alves P S, Camilo E A SCOT - SGPT ratios. Letter. Digest Dis Sc. 1981; 26: 284.
26. Chanarin I Haemopoiesis and alcohol. Brit Med Bull. 1982; 38: 81-86.
27. Chalmers D M, Chanarin I, MacDermott S, Levi A S Sex-related differences in the haematological effects of excessive alcohol consumption. J Clin Pathol. 1980; 33: 3-7.
28. Chalmers D M, Rinsler M G, MacDermott S, Spicer C C, Levi A J Biochemical and haematological indicators of excessive alcohol consumption. Gut. 1981; 22: 992-996.
29. Korri U M, Nuutinen H, Salaspuro M Increased blood acetate: a new laboratory marker of alcoholism and heavy drinking. Alcoholism: Clin Exp Res. 1985; 9: 468-471.
30. Morgan M Y, Camilo M E, Luck W, Sherlock S, Hoffbrand A V Macrocytosis in alcohol-related liver disease: its value for screening. Clin Lab Haematol. 1981; 3: 35-44.
31. Morse R M, Hurt R D Screening for Alcoholism. JAMA. 1979; 242: 2688-2690.
32. Tonnesen H, Hejberg L, Frobenius S, Andersen J R Erythrocyte mean cell volume - correlation to drinking pattern in heavy alcoholics. Acta Med Scand. 1986; 219: 515-518.
33. Unger K W, Johnson D Jr Red blood cell mean corpuscular volume: a potential indicator of alcohol usage in a working population. Am J Med Sci. 1974; 267: 281-289.
34. Wu A, Chanarin I, Levi A J Macrocytosis of Chronic Alcoholism. Lancet 1. 1974; 829-830.
35. Carney M W P, Sheffield B Serum folate and B12 and haematological status of in-patient alcoholics. Brit J Addict. 1978; 73: 3-7.
36. Renwick J H, Asker R L. The time course of response of erythrocyte volume to ethanol and to its withdrawal. Clin Lab Haematol. 1982; 4: 325-326.
37. Stibler H, Allgulander C, Borg S, Kjellin K G Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand. 1978; 204: 49-56.
38. Stibler H, Borg S, Allgulander C Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption. Acta Med Scand. 1979; 206: 275-281.
39. Stibler H, Borg S; Allgulander C Abnormal microheterogeneity of transferrin - a new marker of alcoholism. Subst Alcohol Actions Misuse. 1980; 1: 247-252.
40. Behrens U J, Worner T M, Lieber C S Changes in carbohydrate-deficient transferrin levels after alcohol withdrawal. Alcoholism: Clin Exp Res. 1988; 12: 539-544.
41. Gjerde H, Johnson J, Bjoerneboe G E, Moerland J A comparison of serum carbohydrate-deficient transferrin with other biological markers of excessive drinking. Scand J Clin Lab Inv. 1988; 48: 1-6.
42. Kapur A, Wild G, Milford-Ward A, Triger D R Carbohydrate deficient transferrin: a marker for alcohol abuse. Br Med J. 1989; 299: 427-431.
43. Meregalli M, Giacomini V, Lino S, Marchetti L, DeFeo T, Cappellini M D, Fioreili G Carbohydrate-deficient transferrin in alcohol and nonalcohol abusers with liver disease. Alcoholism: Clin Exp Res. 1995; 19: 1525-1527.
44. Schellenberg F, Weill J Serum desialotransferrin in the detection ot alcohol abuse. Definition of a Tf index. Drug Alcohol Depen. 1987; 19: 181-191.
45. Schellenberg F, Benard J Y, leGroff A M, Bourdin C, Weill J Evaluation of carbohydrate-deficient transferrin compared with Tf index and other markers of alcohol abuse. Alcoholism: Clin Exp Res. 1989; 13: 605-610.
46. Stibler H, Borg S Carbohydrate composition of serum transferrin in alcoholic patients. Alcoholism. 1986: 10:61-64.
47. Stibler H, Hulterantz R Carbohydrate-deficient transferrin in serum in patients with liver diseases. Alcoholism: Clin Exp Res. 1987; 11: 468-473.
48. Storey E L, Anderson G J, Mack U, Powell L W, Halliday J W Desialyted transferrin as a serological marker of chronic excessive alcohol ingestion. Lancet 1. 1987; 1292-1294.
49. Takase S, Takada A, Tsutsumi M, Matsuda Y Biochemical Markers of Chronic Alcoholism. Alcohol. 1985; 2: 405-410.
50. Helander A, Fors M, Zakrisson B Study of Axis-Shield new %CDT immonoassay for quantification of carbohydrate-deficient transferrin (CDT) in serum. Alcohol Alcoholism. 2001; 36: 406-412.
51. Behrens U J, Worner T M, Braly L F, Schaffner F, Lieber C S Carbohydrate-deficient transferrin, a marker for chronic alcohol consumption in different ethnic populations. Alcoholism: Clin Exp Res. 1988; 12: 427-432.
52. Bell H, Tallaksen C, Sjåheim T, Weberg R, Raknerud N, Ørjasa;ter H, Try K, Haug E Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. Alcoholism: Clin Exp Res. 1993; 17: 71-76.
53. Litten R Z, Allen J P, Fertig J B γ-glutamyltranspeptidase and carbohydrate deficient transferrin: alternative measures of excessive alcohol consumption. Alcoholism: Clin Exp Res. 1995; 19: 1541-1546.
54. Stibler H Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem. 1991; 37: 2029-2037.
55. Weidinger S, Schwarzfischer F, Cleve H Classification of transferrin (Tf) subtypes by isoelectric focusing. Z Rechtsmed. 1980; 85: 255-261.
56. Weidinger S, Cleve H, Schwarzfischer F, Postel W, Weser J, Görg A Transferrin subtypes and variants in Germany; further evidence for a Tf null allele. Hum Genet. 1984; 66: 356-360.
57. Gilg T, Weidinger S, Josphi E, Tutsch-Bauer E, v. Meyer L, Bieger W P Bestimmung von CDT (Carbohydrate Deficient Transferrin), γ-GT, Methanol, Isopropanol und Ethanol in forensischen Blutproben zur Beurteilung eines chronischen Alkoholmißbrauchs. Lab Med. 1994; 18: 143-153.
58. Stibler H, Borg S, Joustra M Micro anion exchange chromatography of carbohydrate-deficient transferrin in serum in relation to alcohol consumption (Swedish patent 8400587-5). Alcoholism: Clin Exp Res. 1986; 10: 535-544.
59. Seidl S. Wolf C Zur Bedeutung des Alkoholmarkers CDT für die Fahreignungs-Oberbegutachtung. Blutalkohol. 1998; 35: 48-55.
60. th International Conference on Alcohol. Drugs and Traffic Safety. Annecy: CERMT; 1997. p. 229-240.
61. Heinemann A, Püschel K Sensitivität des CD-Transferrin als Indikator für problematische Alkoholkonsummuster im Straßenverkehr - Bedeutung für die medizinisch-psychologische Begutachtung. Abstract. In: Klein A, editor. Abstracts der 76. Jahrestagung der Deutschen Gesellschaft für Rechtsmedizin. Jena; 1997. p. 124.
62. Contaldo F, d'Arrigo E, Carandente V, Cortese C, Coltorti A, Mancini M, Taskinen M R, Nikkilä E A Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal men. Metabolism. 1989; 38: 166-171.
63. Suter P M Alkohol und Stoffwechsel. In: Singer M V, Teyssen S, editors. Alkohol und Alkoholfolgekrankheiten. Berlin, Heidelberg, New York: Springer; 1999. p. 283-294.
64. Rietbrock N Kinetik und Wege des Methanolumsatzes. Arch Pharmakol Exp Path. 1969; 263: 88-105.
65. Röe O Species differences in methanol poisoning. Crit Rev Toxicol. 1982; 10: 275-286.
66. Blair A H, Vallee B L Some catalytic properties of human liver alcohol dehydrogenase. Biochemistry. 1966; 5: 2026-2034.
67. Jones A W, Sternebring B Kinetics of ethanol and methanol in alcoholics during detoxification. Alcohol Alcoholism. 1992; 27: 641-647.
68. Majchrowicz E, Mendelson J H Blood methanol concentrations during experimentally induced ethanol intoxication in alcoholics. J Pharmacol Exp Ther. 1971; 179: 293-300.
69. Mani J C, Pietruszko R, Theorell H Methanol activity of alcohol dehydrogenases from human liver, horse liver, and yeast. Arch Biochem Biophys. 1970; 140: 52-59.
70. Gilg T, Deinl I, Grundner H, Soyka M Stellenwert von Begleitstoffanalytik (Methanol, Isopropanol) und CD-Transferrin (CDT) in der Alkoholismusdiagnostik. In: Soyka M, editor. Biologische Alkoholismusmarker. Weinheim: Chapman & Hall; 1995. p. 45-91.
71. Gilg T, v. Meyer L, Liebhardt E, Schwabe U, Scholz R Methanolbildung in der perfundierten Rattenleber beim Fremdstoffabbau unter Äthanolbelastung. Blutalkohol. 1987; 24: 316-320.
72. Roine R P, Eriksson C J P, Ylikahri R, Penttilä A, Salaspuro M Methanol as a marker of alcohol abuse. Alcoholism: Clin Exp Res. 1989; 13: 172-175.
73. Soyka M, Gilg T, v. Meyer L, Ora I Methanolstoffwechsel bei chronischem Alkoholismus. Wien Klin Wochenschr. 1991; 103: 684-689.
74. th International Conference on Alcohol, Drugs and Traffic Safety. Annecy: CERMT; 1997. p. 223-228.
75. Helander A, Beck O, Jacobsson G, Wikström T, Borg S Characterization of elevated urinary 5-hydroxytryptophol as a marker of recent alcohol consumption. Abstract. Alcoholism: Clin Exp Res. 1992; 16: 607.
76. Voltaire A, Beck O, Borg S Urinary 5-hydroxytryptophol: a possible marker of recent alcohol consumption. Alcoholism: Clin Exp Res. 1992; 16: 281-285.
77. Helander A, Voltaire Carlsson A, Borg S Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyl transferase: Complementary markers of excessive alcohol consumption. Alcohol Alcoholism. 1996; 31: 101-107.
78. Helander A, Wikström T, Löwenmo C, Jacobsson G, Beck O Urinary excretion of 5-hydroxyindole-3-acetic acid and 5-hydroxytryptophol after oral loading with serotonin. Life Sci. 1992; 50: 1207-1213.
79. Davis P L, Dal Cortivo L A, Mature J Endogenous isopropanol: forensic and biochemical implications. J Anal Toxicol. 1984; 8: 209-212.
80. Iffland R, Balling P, Borsch G, Herold C, Kaschade W, Löffler T, Schmidtmann U, Stettner J Zur Wertung erhöhter Spiegel von GGT, CDT, Methanol, Aceton und Isopropanol im Blut alkoholauffälliger Kraftfahrer - Alkoholismusindikatoren anstelle medizinischer Untersuchungen? Blutalkohol. 1994; 31: 273-314.
81. Iffland R, Staak M Methanol und Isopropanol als Alkoholismusmarker. Beitr Gerichtl Med. 1990; 48: 173-177.
82. Iffland R, Balling P, Oehmichen M, Lieder F, Norpoth T Methanol, Isopropanol, n-Propanol - endogene Bildung unter Ethanoleinfluß? Blutalkohol. 1989; 26: 87-97.
83. Iffland R, Schmidt V, Oehmichen M Aceton- und Isopropanol-Konzentration im Blut. Abhängigkeit vom akuten und chronischen Alkoholkonsum (Alkoholismus). Blutalkohol. 1988; 25: 80-96.
84. Pullarkat R K, Raguthu S Elevated urinary dolichol levels in chronic alcoholics. Alcoholism: Clin Exp Res. 1985; 9: 28-30.
85. Roine R P, Turpeinen U, Ylikahri R, Salaspuro M Urinary dolichol - a new marker of alcoholism. Alcoholism: Clin Exp Res. 1987; 11: 525-527.
86. Roine R P, Ylikahri R, Koskinen P, Suokas A, Hämäläinen J, Salaspuro M Effect of heavy weekend drinking on urinary dolichol levels. Alcohol. 1987; 4: 509-511.
87. Roine R P Effects of moderate drinking and alcohol abstinence on urinary dolichol levels. Alcohol. 1988; 5: 229-231.
88. Roine R, Heinonen T, Salmela K, Heikkonen E, Suokas A, Luurila O J, Koskinen P, Palo J, Salaspuro M Strenous physical activity, aspirin and heat stress increase urinary dolichols: evidence for lysosomal origin of urinary dolichols. Clin Chim Acta. 1991; 204: 13-22.
89. Roine R, Humaloja K, Hämäläinen J, Nykänen I, Ylikahri R, Salaspuro M Significant increases in urinary dolichol levels in bacterial infections, malignancies and pregnancy but not in other clinical conditions. Ann Med. 1989; 21: 13-16.
90. Adachi J, Mizoi Y, Fukunaga T Individual difference in urinary excretion of salsolinol in alcoholic patients. Alcohol Alcoholism. 1980; 3: 371-376.
91. Collins M A, Nijm W P, Borge G F, Teas G, Goldfarb C Dopamine-related tetrahydroisoquinolines: significant urinary excretion by alcoholics after alcohol consumption. Science. 1979; 206: 1184-1186.
92. Faraj B A, Camp V M, Davis D C, Lenton J D, Kutner M Elevation of plasma salsolinol sulfate in chronic alcoholics as compared to nonalcoholics. Alcoholism: Clin Exp Res. 1989; 13: 155-163.
93. Sjöquist B, Borg S, Kvande H Salsolinol and methylated salsolinol in urine and cerebrospinal fluid from healthy volunteers. Subst Alcohol Actions Misuse. 1984; 2: 73-77.
94. Feest U, Kemper A, Nickel B, Rabe H, Koalick F Comparison of salsolinol excretion in alcoholics and non-alcoholic controls. Alcohol. 1992; 9: 49-52.
95. Schmitt G, Aderjan R, Keller T, Wu M Ethyl glucuronide: an unusual ethanol metabolite in humans. Synthesis, analytical data, and determination in serum and urine. J Anal Toxicol. 1995; 19: 91-94.
96. Wurst F M, Seidl S, Sachs H, Besserer K, Reinhardt G, Schüttler R Ethylglucuronide - evaluation of a new marker of alcoholism. Abstract. Alcohol Alcoholism. 1995; 30: 560.
97. Wurst F M, Seidl S, Sachs H, Gilg T, Hirsch M, Reinhardt G. Schüttler R Ethylglucuronide - evaluation of a new marker of alcoholism and comparison to traditional alcohol markers. J Neurol. 1996; 243: 24-25.
98. Wurst F M, Seidl S, Sachs H, Besserer K, Reinhardt G, Schüttler R Ethylglucuronid - Evaluation eines neuen Alkoholmarkers. In: Möller H J, Müller-Spahn F, Kurtz G, editors. Aktuelle Perspektiven der Biologischen Psychiatrie. Wien, New York: Springer, 1996. p. 378-380.
99. 5-Ethylglucuronid. Blutalkohol. 1997; 34: 360-365.
100. Sticht G, Käferstein H, Staak M GC-MS-Bestimmung von Ethylglucuronid im Serum mit Propylglucuronid als internem Standard. Rechtsmedizin. 1997; 7: 184-188.
101. Schmitt G, Drönner P, Skopp G, Aderjan R Ethyl glucuronide concentrations in serum of human volunteers, teetotalers, and suspected drinking drivers. J Forensic Sci. 1997; 42: 1099-1102.
102. Schmitt G, Aderjan R, Kirchner M, Zimmer H Enzymimmunoassay und GC/MS zur Bestimmung von Ethylglucuronid in Serum und Urin. Blutalkohol. 1998; 35: 428-433.
103. Nishikawa M, Tsuchihashi H, Miki A, Katagi M, Schmitt G, Zimmer H, KellerT. Aderjan R Determination of ethyl glucuronide, a minor metabolite of ethanol, in human serum by liquid chromatography - electrospray ionization mass spectrometry. J Chromatogr B. 1999; 726: 105-110.
104. Wurst F M, Schüttler R, Kempter Ch, Seidl S, Gilg Th, Jachau K, Alt A Can ethyl glucuronide be determined in post modern body fluids and tissues? Alcohol Alcohol. 1999; 34: 262-263.
105. Seidl S, Wurst F M, Alt A Überprüfung einer Abstinenzbehauptung in der Fahreignungs-Oberbegutachtung mit Hilfe des Ethanolmetaboliten Ethylglucuronid (EtG). Blutalkohol. 1998; 35: 174-182.
106. Wurst F M, Kempter C, Metzger J, Seidl S, Alt A Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications. Alcohol. 2000; 20: 111-116.
107. Skopp G, Schmitt G, Pötsch L, Drönner P, Aderjan R, Mattern R Ethyl glucuronide in human hair. Alcohol Alcohol. 2000; 35: 283-285.
108. Alt A, Janda I, Seidl S, Wurst F M Determination of ethyl glucuronide in hair samples. Alcohol Alcohol. 2000; 35: 313-314.
109. Seidl S, Wurst F M, Alt A Der Einsatz des Ethanolmetaboliten Ethylglucuronid (EtG) in der Fahreignungs-Oberbegutachtung. In: Bundesanstalt für Straßenwesen, editor. Kongressbericht 1999 der Deutschen Gesellschaft für Verkehrsmedizin. Bremerhaven: Wirtschaftsverlag NW; 1999. p. 174-179.
110. Monteiro M G, Masur J Diagnostic of alcoholism: How useful is the combination of gamma glutamyl transferase with different biochemical markers? Drug Alcohol Depen. 1986; 16: 31-37.